Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028309 |
---|---|
Receipt number | R000032367 |
Scientific Title | A multicenter phase II study of S-1+ramucirumab as first line treatment in elderly patients with advanced/recurrent gastric cancer(KSCC1701) |
Date of disclosure of the study information | 2017/07/20 |
Last modified on | 2021/01/07 11:04:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/07/20 22:18:10 | ||
2 | Update | 2017/07/20 22:39:16 | UMIN ID3 |
|
3 | Update | 2018/01/18 09:15:57 | Recruitment status |
|
4 | Update | 2018/01/18 09:26:48 | Institutions |
|
5 | Update | 2019/01/19 12:56:12 | Email |
|
6 | Update | 2019/07/30 22:21:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Organization Organization Zip code Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name TEL Organization Organization Address Address Tel |
|
7 | Update | 2019/07/30 22:23:59 | Date of IRB Last follow-up date |
|
8 | Update | 2021/01/07 11:04:40 | Recruitment status |